Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    China SXT Pharmaceuticals...

    NASDAQ: SXTC · Real-Time Price · USD
    1.72
    -0.02 (-1.15%)
    At close: Jun 27, 2025, 3:59 PM
    1.65
    -3.79%
    After-hours: Jun 27, 2025, 04:20 PM EDT

    China SXT Pharmaceuticals Statistics

    Share Statistics

    China SXT Pharmaceuticals has 26.03M shares outstanding. The number of shares has increased by 15027.17% in one year.

    Shares Outstanding

    n/a
    		 26.03M

    Shares Change (YoY)

    n/a
    		 15027.17%

    Shares Change (QoQ)

    n/a
    		 3067.53%

    Owned by Institutions (%)

    n/a
    		 0.04%

    Shares Floating

    n/a
    		 25.96M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,002

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    The latest short interest is 245.96K, so 0.21% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 245.96K

    Short % of Shares Out

    n/a
    		 0.21%

    Short % of Float

    n/a
    		 0.21%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -3.72 and the forward PE ratio is null. China SXT Pharmaceuticals's PEG ratio is 0.04.

    PE Ratio

    n/a
    		 -3.72

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 5.97

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.83

    P/FCF Ratio

    n/a
    		 -5.95

    PEG Ratio

    n/a
    		 0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for China SXT Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.6, with a Debt / Equity ratio of 0.19.

    Current Ratio

    n/a
    		 1.6

    Quick Ratio

    n/a
    		 1.51

    Debt / Equity

    n/a
    		 0.19

    Debt / EBITDA

    n/a
    		 -1.13

    Debt / FCF

    n/a
    		 -1.37

    Interest Coverage

    n/a
    		 -4.62

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $25,713.29

    Profits Per Employee

    n/a
    		 $-41,313.76

    Employee Count

    n/a
    		 75

    Asset Turnover

    n/a
    		 0.08

    Inventory Turnover

    n/a
    		 1.7

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -80.28% in the last 52 weeks. The beta is 1.1, so China SXT Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.1

    52-Week Price Change

    n/a
    		 -80.28%

    50-Day Moving Average

    n/a
    		 1.77

    200-Day Moving Average

    n/a
    		 3.26

    Relative Strength Index (RSI)

    n/a
    		 47.91

    Average Volume (20 Days)

    n/a
    		 4,445,825

    Income Statement

    In the last 12 months, China SXT Pharmaceuticals had revenue of 1.93M and earned -3.1M in profits. Earnings per share was -3.57.

    Revenue

    n/a
    		 1.93M

    Gross Profit

    n/a
    		 553.97K

    Operating Income

    n/a
    		 -2.52M

    Net Income

    n/a
    		 -3.1M

    EBITDA

    n/a
    		 -2.35M

    EBIT

    n/a
    		 -2.55M

    Earnings Per Share (EPS)

    n/a
    		 -3.57
    Full Income Statement

    Balance Sheet

    The company has 12.07M in cash and 2.65M in debt, giving a net cash position of 9.42M.

    Cash & Cash Equivalents

    n/a
    		 12.07M

    Total Debt

    n/a
    		 2.65M

    Net Cash

    n/a
    		 9.42M

    Retained Earnings

    n/a
    		 -24.71M

    Total Assets

    n/a
    		 23.13M

    Working Capital

    n/a
    		 5.33M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -1.93M and capital expenditures -7.06K, giving a free cash flow of -1.94M.

    Operating Cash Flow

    n/a
    		 -1.93M

    Capital Expenditures

    n/a
    		 -7.06K

    Free Cash Flow

    n/a
    		 -1.94M

    FCF Per Share

    n/a
    		 -2.23
    Full Cash Flow Statement

    Margins

    Gross margin is 28.73%, with operating and profit margins of -130.42% and -160.67%.

    Gross Margin

    n/a
    		 28.73%

    Operating Margin

    n/a
    		 -130.42%

    Pretax Margin

    n/a
    		 -160.67%

    Profit Margin

    n/a
    		 -160.67%

    EBITDA Margin

    n/a
    		 -121.91%

    EBIT Margin

    n/a
    		 -130.42%

    FCF Margin

    n/a
    		 -100.34%

    Dividends & Yields

    SXTC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for SXTC.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 5, 2023. It was a backward split with a ratio of 1:25.

    Last Split Date

    n/a
    		 Oct 5, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:25

    Scores

    Altman Z-Score

    n/a
    		 1.06

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist